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Novel Female Sex-Dependent Actions of Oestrogen in the Intestine 
 
Fiona O’Mahony, Warren Thomas and Brian J. Harvey 
 
Abstract 
The intestine is an oestrogen responsive organ and circulatory oestrogens suppress Cl- 
secretion across the epithelium of the colon to promote fluid retention at the estrus stage 
of the menstrual cycle. Ion transporters in the colon which are involved in Cl- secretion 
show differential expression between males and females as do the signalling  protein 
kinase intermediates involved in acutely regulating these transporters. Work from our 
laboratory has identified the KCNQ1/KCNE3 channel as one of the principal targets for 
oestrogen-induced signalling cascades in the distal colon. Through inhibition of the 
KCNQ1 channel, basolateral K+ recycling is decreased so reducing the favourable 
electrochemical gradient for Cl- extrusion at the apical membrane. The actions of 
oestrogen on non-reproductive tissues such as the colon, kidney, lung and sweat gland 
will affect whole body electrolyte and fluid homeostasis and also has consequences for 
reproductive potential. 
 Figure 1.  Mechanism of 
rapid oestrogen inhibition of 
cAMP activated chloride ion 
secretion and subsequent 
induction of fluid retention in  
the isolated distal colon from 
female rats. Cl- ions enter the 
cell via the basolateral 
NKCC1 protein and exit via 
apical CFTR. Na+ and K+ 
recycling occur via the Na+ 
K+ ATPase pump and the 
KCNQ1 channel at the 
basolateral membrane. 
Oestrogen rapidly activates 
PKCδ (2 min), which in turn 
activates PKA. The kinase complex translocates to the plasma membrane and associates 
with the cytoplasmic region of the KCNQ1 channel. PKA induces a rapid serine 
phosphorylation of the channel. Phosphorylation of the KCNQ1 channel results in an 
inhibition of K+ recycling and in turn inhibition of Cl- secretion. In addition to inducing 
the rapid and anti-secretory effect, oestrogen induces a transcriptional response via 
CREB resulting in the up-regulation of expression of PKCδ and down-regulation of the 
expression of ion transporters. In this way the rapid ‘non-genomic’ effects of oestrogen 
promote transcriptional priming of signalling intermediates of the anti-secretory 
response and also feed-forward to sustain the anti-secretion through inhibition of ion 
transporter expression and activation of inhibitory protein kinases.  
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Introduction 
Oestrogen is the primary female reproductive hormone and exerts biological effects 
through the modulation of transcriptional and cell signalling processes in target tissues 
(1). Oestrogen regulates cell growth and differentiation in primary and secondary 
reproductive organs but also acts on what are generally regarded as non-reproductive 
tissues expressing oestrogen receptors (ERs). The role of oestrogen in modulating the  
physiology of non-reproductive tissues is an emerging area of investigation. ERs are 
expressed in the respiratory tract, kidney, sweat gland and colon as well as at sites in the 
brain (2). The prominence of secretory and absorptive epithelia among the list of 
oestrogen target tissues suggests an important role for oestrogen in the regulation of 
whole body electrolyte and fluid balance through the modulation of ion transport 
processes (3, 4). Over the course of the oestrous cycle large fluctuations in circulatory 
oestrogen concentrations are experienced by the female body and these changes 
modulate the structure and function of reproductive tissues, particularly the uterus to 
facilitate embryo implantation. Through oestrogen synthesis and release by the ovaries, 
the ion transport activities of epithelial tissues such as the distal colon are also 
synchronized with the female reproductive cycle. The importance of oestrogen action on 
epithelial ion transport to the physiological processes of conception, implantation and 
pregnancy are still unknown.   
 
The two isoforms of the oestrogen receptor, ERα and ERβ, show marked differential 
tissue expression and biological roles. The receptors act as ligand-dependent 
transcription factors to positively or negatively regulate the expression of a broad 
repertoire of oestrogen responsive genes. While bound to oestrogen, these receptors 
interact with specific DNA sequences to facilitate the assembly of the transcription pre-
initiation complexes at gene promoter sites. It is also now clear that ERs interact with 
adjacent transcription factors at cis elements in promoter sequences to regulate 
transcription in a far more subtle manner than was previously imagined. Reports over 
the last two decades have shown that oestrogen and other steroid hormones also 
stimulate the rapid activation of protein kinase signalling cascades in target tissues that 
potentiate and modulate the direct transcriptional effects of the nuclear ERs. These rapid 
‘non’genomic’ signalling events are initiated at membrane localized oestrogen receptors 
(5-7) which may be splice variants of  the nuclear receptor (8, 9) or may be truncated 
forms of the ERα  associated with the cell membrane through acylation (10). Even 
though the rapid activation of protein kinases by oestrogen has been established, the 
biological role of these responses is only now being elucidated. We have identified a 
role for oestrogen-induced protein kinase signalling cascades in the suppression of fluid 
secretion in the distal colon which represents a novel and important facet in the 
hormone’s range of physiological effects (11). 
 
Oestrogen and Colonic Physiology 
The distal colon is the principal site for water conservation in the body. The transport of 
ions, particularly Na+ absorption and Cl- secretion across the epithelium, determines the 
rate of water loss and recovery from the lumen of the colon. Disruption of this 
equilibrium results in conditions such as secretory diarrhoea. The absorption of water 
from the faeces is coupled to Na+ absorption through the Na+/H+ exchanger or through 
the epithelial Na+ channel (ENaC). Cl- driven secretion serves to hydrate the mucosa 
and also lubricates the passage of the faecal matter through the colon (12). Cl- is 
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transported into the epithelial cells of the colon at the basolateral surface through the 
Na+/K+/2Cl- (NKCC1) co-transporter and exits the cell across the apical membrane into 
the lumen through the cystic fibrosis trans-membrane conductance regulator (CFTR). 
The Na+/K+-ATPase at the basolateral membrane provides the driving force for apical 
Cl- secretion and ENaC-dependent Na+ absorption, while the electrochemical gradient is 
maintained by K+ recycling through basolateral K+ channels such as KCNQ1 (13). 
KCNQ1 plays a crucial role in regulating the rate of salt and water transport across a 
number of epithelia including that of the small intestine, nephron and colon (14). The 
transporters engaged in electrolyte transport processes across the colon and other 
epithelia are subject to precise transcriptional control while acutely acting secretagogues 
such as forskolin or carbachol modulate transporter activity through the stimulation of 
signalling cascades coupled to intracellular cAMP or Ca2+ , respectively. We have found 
that oestrogen suppresses the secretagogue-induced Cl- secretion in the distal colon 
suggesting that the hormone may also have an anti-secretory role in normal colon 
physiology (Figure 1) (15). The observation that antagonism of basolateral K+ recycling 
also attenuates Cl- secretion and so mimics the effects of oestrogen in the colon gave an 
insight into a potential mechanism by which oestrogen could produce its anti-secretory 
effect (16). Furthermore, in cardiac tissue oestrogen suppresses the KCNQ1-mediated 
K+ current suggesting this channel subunit could be a potential molecular target for 
oestrogen anti-secretory action (17). 
 
Oestrogen and the Colonic Epithelium 
The epithelium of the colon expresses both ERα and ERβ (18). However, in the crypts 
of the proximal colon ERα is expressed more highly at the base of the crypt while ERβ 
expression is predominant in the mid-section of the crypt and in the lumen surface cells 
(19). This segregation of ER isoform expression suggests antagonistic roles for the two 
receptors and differential effects of circulatory oestrogen on the physiological function 
of the cells located at different sites along the crypt. Progenitor cell proliferation at the 
base of the crypt gives way to enterocyte differentiation in the midsection and shedding 
of senescent or apoptotic cells at the lumen surface. ERβ has been proposed as a tumour 
suppressor in colorectal cancer (CRC). ERβ expression is selectively lost during tumour 
progression through methylation-dependent gene silencing (20) and hormone 
replacement therapy (HRT) reduces the incidence of CRC in postmenopausal women 
(21, 22). Recent data suggests that HRT may also be protective in suppressing episodes 
of inflammatory bowel disease in post-menopausal women through the anti-
inflammatory effects of oestrogen (23). The role of oestrogen in regulating normal 
colon physiology and ion transport is less well characterized. However, studies with 
ERβ -/- mice demonstrated a role for the receptor in cell differentiation and the 
organization of colon tissue architecture through regulation of cell to cell interactions 
such as tight junction and desmosome assembly (24). In our studies, we have used 
isolated rat colonic crypts as an experimental model to study the role of oestrogen in 
suppressing agonist-induced Cl- secretion and K+ recycling. KCNQ1 is a voltage-gated, 
low conductance K+ channel activated during cAMP-stimulated Cl- secretion in the 
colon (25). We found that the activity of this channel was suppressed following 
oestrogen treatment at physiological levels of the hormone. The oestrogen effect was 
non-additive to the effects of Chromanol 293B, a specific blocker of KCNQ1, so 
confirming this channel as an important effector of the oestrogen anti-secretory 
response. The anti-secretory action of oestrogen is superimposed upon an ion 
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transporter protein expression profile that differs between males and females. NKCC1, 
CFTR and Na+/K+-ATPase α-subunit are all expressed at lower abundance in colonic 
crypts isolated from female rats  compared to males (11). The KCNQ1 channel subunit 
is not differentially expressed in the male and female colonic epithelium, however the 
expression of the KCNE3 regulatory subunit is less abundant in females compared to 
males (11).  
 
Oestrogen-Induced Signalling in the Colon 
Oestrogen suppresses forskolin-induced secretion in the distal colon within 10 minutes 
of hormone treatment suggesting that the effect is at least in part modulated by a 
signalling cascade rather than by a direct transcriptional response (15). The involvement 
of a protein kinase signalling cascade was confirmed by the sensitivity of the oestrogen 
effect to PKC antagonism (15, 16, 26). The phosphorylation of membrane transporters 
is an important regulatory mechanism contributing either to the direct activation of the 
transporter or to its localization at the cell membrane. KCNQ1 exists at the cell 
membrane as part of a multi-molecular complex with the A-kinase anchoring protein 
Yotiao and a regulatory β subunit. KCNQ1 is phosphorylated at residue Ser27 by 
membrane associated PKA to modulate its activity in the heart (27). In the distal colon 
KCNQ1 is in complex with the KCNE3 regulatory subunit. In common with the anti-
secretory effect of oestrogen on the colon, the suppression of KCNQ1 activity by 
oestrogen in the colon was female gender-specific (28). We also found that oestrogen 
stimulated the rapid activation of PKA in isolated female colonic crypts but not in 
crypts isolated from male rats (28). The level of PKA phosphorylation induced by 
oestrogen correlates with the degree of  stimulation or suppression of KCNQ1 activity. 
The activation of different PKA isoforms, which localize to different cellular sites, have 
different physiological consequences. PKA activation in oestrogen treated colonic 
crypts is localized to the cytosol rather than to the cell membrane (29). PKA isoform II 
is anchored to the cell membrane while PKA I is distributed to pools in the cytosol (30). 
Oestrogen treatment stimulates the physical association of the cytosolic PKA-CI 
isoform with KCNQ1 whereas the membrane associated PKA is unaffected,  The  
physical interaction of PKA-CI : KCNQ1 correlates with the oestrogen-induced serine 
phosphorylation of the KCNQ1 channel protein (28). The oestrogen-induced inhibition 
of Cl- secretion and KCNQ1 activity, and the stimulation of PKA-dependent 
phosphorylation of KCNQ1 were all antagonized by prior inhibition of PKCδ (28). 
Recent data points to the differential expression of key protein kinase signalling 
intermediates in tissues from males as compared to females. At least some of these 
differentially regulated molecules contribute to steroid-induced responses or are 
themselves transcriptionally regulated by oestrogen (31). Gender differences in PKCδ 
abundance has been found in aortic smooth muscle (32) and in the liver (33). The 
abundance of PKCδ in isolated colonic crypts from rats at the estrus stage of the 
reproductive cycle was on average four-fold higher in females compared to males, while 
females at the proestrus stage of the cycle express PKCδ at low levels equivalent to 
males (28). Through the modulation of protein kinase expression, varying circulating 
levels of oestrogen determine the sensitivity of particular cell signalling cascades to the 
rapid actions of the hormone. Oestrogen-induced PKCδ expression effectively creates a 
positive feed-back loop that amplifies PKCδ-dependent oestrogen rapid and genomic 
responses at the peak of circulatory levels of oestrogen . 
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Conclusion 
Oestrogen modulates the rate of fluid secretion across the female colonic epithelium 
over the course of the oestrous cycle. Cl- and fluid secretion are attenuated at the estrus 
phase of the cycle by the suppression of basolateral K+ recycling through the KCNQ1 
channel. Oestrogen acutely suppresses KCNQ1 activity through phosphorylation of the 
channel α subunit, which is dependent on the activation of PKCδ and cytosolic PKA. 
The expression of PKCδ by the colonic epithelium is modulated throughout the oestrous 
cycle to amplify the kinase-dependent regulation of KCNQ1 during the estrus phase. 
Precise regulation of Cl- secretion by the colon at key stages of the reproductive cycle 
facilitates fluid conservation at a time that is coincident with uterine restructuring and 
represents a novel facet to the role of oestrogen in the physiology of reproduction.  
 
Figure 2.  High circulating 
levels of oestrogen occurring 
during the implantation 
window of the estrous cycle 
(and with hormone 
replacement therapy and the 
contraceptive pill) produce an 
inhibition of chloride ion 
secretion in the intestine and 
lung and increase the 
absorption of sodium in the 
kidney, resulting in increased 
fluid retention which is 
necessary for endometrial 
expansion and implantation of 
the blastocyst. 
 
The intestinal tract has previously not been thought of as a sex-steroid targeted organ. 
Inter-organ interactions have previously been reported between the reproductive, 
urinary and intestinal systems (22). The identification of functional ER in the intestine 
indicate a physiological role of oestrogen in the intestine (18). This review highlights 
the important role for oestrogen in the distal colon in contributing to the regulation of 
whole body fluid and electrolyte regulation in the female.  In preparation for the 
implantation of the blastocyst, the endometrial lining must expand its vasculature and 
this is associated with a significant increase in tissue wet weight. High levels of 
oestrogen result in fluid retention as a result of conservation of large volumes of water 
from organs such as the kidney, lung and large intestine (Figure 2). This process is a 
rapid  and reversible event as whole body fluid retention of water is cyclical and occurs 
over short periods of time. In this manner the intestine responds to fluctuating levels of 
oestrogen  to rapidly and dynamically reduce water loss via inhibition of the Cl- 
secretory pathway.    
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